Robert Borkowski
Interventional Cardiology · New Britain, CTNPI 1801852074
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 456 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,756 and has fallen 99.1% since, to $25 in 2023.
Across 456 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Amarin Pharma, Inc.$1K
- Pfizer$743
- Boehringer Ingelheim$643
- Amgen$468
- Novartis$396
- plus $3K from 22 others
What the payments were for
- Food & beverage$7,75199%
- Education$711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 95 | $1,396 |
| Amarin Pharma, Inc. | 73 | $1,014 |
| Pfizer | 33 | $743 |
| Boehringer Ingelheim | 31 | $643 |
| Amgen | 23 | $468 |
| Novartis | 31 | $396 |
| Esperion Therapeutics, Inc. | 18 | $387 |
| AstraZeneca | 26 | $366 |
| Alnylam Pharmaceuticals Inc. | 14 | $362 |
| E.r. Squibb & Sons, L.L.C. | 21 | $339 |
| Abbott | 18 | $306 |
| Vifor Pharma, Inc. | 6 | $249 |
| Kowa Pharmaceuticals America, Inc. | 16 | $227 |
| Merck | 9 | $152 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $150 |
| Akcea Therapeutics, Inc. | 5 | $106 |
| Sanofi-aventis U.S. LLC | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| Biotronik Inc. | 3 | $67 |
| Lundbeck LLC | 5 | $66 |
| Bardy Diagnostics, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $33 |
| Medtronic | 2 | $29 |
| Lexicon Pharmaceuticals, Inc. | 1 | $25 |
| Amryt Pharma Holdings Ltd | 1 | $20 |
| AbbVie | 1 | $19 |
| Portola Pharmaceuticals, LLC | 1 | $18 |
| Chiesi USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,822 in reported general payments places this provider in the 60th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Other interventional cardiology in New Britain
- Wael ElmallahNew Britain$9K
- Manny KatsetosNew Britain$7K
- Aaron BriceNew Britain$6K
- Amit VoraNew Haven$409K
- Craig ThompsonHartford$222K
- Michael NannaNew Haven$60K
- Jawad HaiderBloomfield$44K
- Sameer NagpalNew Haven$43K
- Khagendra DahalFarmington$42K
- Abdul QaziHartford$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.